For the second year in a row, retroactive pharmacy direct and indirect remuneration fees rank as the top legislative and regulatory priority for members of the National Community Pharmacists Association. More than 37 percent of respondents chose DIR fees as the top concern. This is the fifth year in a row for the annual survey, which enables NCPA’s Advocacy Center to craft an agenda based on member feedback.
“Independent community pharmacists have made it abundantly clear in their responses to NCPA’s survey that relief from retroactive pharmacy DIR fees is their top priority,” said NCPA CEO B. Douglas Hoey, Pharmacist, MBA.
The other top priorities in the NCPA priorities survey include:
- 16.2 percent of respondents identified generic prescription drug transparency to address delays in payment rates and appeals processes as their top priority, which can be fixed by passing H.R. 1316, the Prescription Drug Price Transparency Act.
- 14.2 percent of respondents listed fair and reasonable Medicaid reimbursement to pharmacy as their No. 1 priority, which falls under the purview of states.
- 13.6 percent of respondents said being included in preferred pharmacy networks was most important, which can be addressed by enacting S. 1044 / H.R. 1939, the Ensuring Seniors Access to Local Pharmacies Act.
